Compugen (Israel)
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Compugen (Israel), Israel, covering academic research published from 2000 to 2025. Read More.
Open Access Percentage
53%
Total
Publications
276
Total Open
Publications
146
Total
Citations
18K
Open Access
Percentage
53%
Total
Publications
276
Total Open
Publications
146
Total
Citations
18K
Breakdown
Publisher Open
20%
Both
22%
Other Platform Open
11%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 40%
46
Hybrid 23%
27
No Guarantees 37%
42
Other Platform Open
Domain 56%
51
Institution 41%
37
Preprint 19%
17
Other Internet 8%
7
Public 7%
6
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 51 |
doaj.org OAI-PMH Repository | Institution | 23 |
LA Referencia | Institution | 8 |
arXiv | Preprint | 8 |
DOI | Other Internet | 6 |
Research Square | Preprint | 5 |
aecid.es OAI-PMH Repository | Institution | 5 |
bioRxiv | Preprint | 4 |
Zenodo | Public | 3 |
Office of Scientific and Technical Information | Institution | 3 |